Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India

por Karade, Santosh K., Ghate, Manisha V., Chaturbhuj, Devidas N., Kadam, Dileep B., Shankar, Subramanian, Gaikwad, Nitin, Gurav, Shraddha, Joshi, Rajneesh, Sane, Suvarna S., Kulkarni, Smita S., Kurle, Swarali N., Paranjape, Ramesh S., Rewari, Bharat B., Gangakhedkar, Raman R.
Publicado 2016

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India

por Kulkarni, Prasad S, Padmapriyadarsini, Chandrasekaran, Vekemans, Johan, Bavdekar, Ashish, Gupta, Madhu, Kulkarni, Praveen, Garg, B S, Gogtay, Nithya J, Tambe, Muralidhar, Lalwani, Sanjay, Singh, Kiranjit, Munshi, Renuka, Meshram, Sushant, Selvavinayagam, T S, Pandey, Krishna, Bhimarasetty, Devi Madhavi, Ramakrishnan, S R, Bhamare, Chetanraj, Dharmadhikari, Abhijeet, Vadakkedath, Rajeev, Bonhomme, Cyrille J, Thakar, Madhuri, Kurle, Swarali N, Kelly, Elizabeth J, Gautam, Manish, Gupta, Nivedita, Panda, Samiran, Bhargava, Balram, Shaligram, Umesh, Kapse, Dhananjay, Gunale, Bhagwat
Publicado 2021